Laura Azzopardi

657 total citations
9 papers, 479 citations indexed

About

Laura Azzopardi is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Laura Azzopardi has authored 9 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 5 papers in Immunology and 2 papers in Neurology. Recurrent topics in Laura Azzopardi's work include Multiple Sclerosis Research Studies (5 papers), Immunotherapy and Immune Responses (4 papers) and Peripheral Neuropathies and Disorders (2 papers). Laura Azzopardi is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Immunotherapy and Immune Responses (4 papers) and Peripheral Neuropathies and Disorders (2 papers). Laura Azzopardi collaborates with scholars based in United Kingdom, Australia and Ireland. Laura Azzopardi's co-authors include Alasdair Coles, Joanne Jones, Orla Tuohy, Michael Fahey, Grant Hill-Cawthorne, Alastair Compston, Sara Thompson, Katharine Harding, Jessica L. Davies and Allison J. Curry and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Laura Azzopardi

9 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Azzopardi United Kingdom	6	327	218	138	121	92	9	479
Tom Button United Kingdom	5	292 0.9×	138 0.6×	113 0.8×	91 0.8×	80 0.9×	6	377
Sandra Greer United Kingdom	2	168 0.5×	194 0.9×	67 0.5×	50 0.4×	84 0.9×	3	408
César Álvarez-González United Kingdom	9	258 0.8×	144 0.7×	148 1.1×	105 0.9×	37 0.4×	14	442
Eva Krasulová Czechia	5	196 0.6×	98 0.4×	64 0.5×	71 0.6×	54 0.6×	12	314
Evis Havari United States	11	132 0.4×	218 1.0×	113 0.8×	37 0.3×	29 0.3×	19	449
Hayato Yamazaki Japan	10	366 1.1×	113 0.5×	40 0.3×	311 2.6×	211 2.3×	14	602
N. А. Totolyan Russia	7	528 1.6×	196 0.9×	60 0.4×	446 3.7×	153 1.7×	50	720
T Uede Japan	14	86 0.3×	182 0.8×	71 0.5×	145 1.2×	116 1.3×	49	544
Yann Hyvert United States	7	287 0.9×	213 1.0×	113 0.8×	93 0.8×	52 0.6×	16	438
M. Boggild United Kingdom	9	211 0.6×	80 0.4×	69 0.5×	151 1.2×	74 0.8×	12	579

Countries citing papers authored by Laura Azzopardi

Since Specialization

Citations

This map shows the geographic impact of Laura Azzopardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Azzopardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Azzopardi more than expected).

Fields of papers citing papers by Laura Azzopardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Azzopardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Azzopardi. The network helps show where Laura Azzopardi may publish in the future.

Co-authorship network of co-authors of Laura Azzopardi

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Azzopardi. A scholar is included among the top collaborators of Laura Azzopardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Azzopardi. Laura Azzopardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Azzopardi, Laura, et al.. (2015). Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series. Journal of Neurology. 263(1). 25–29. 33 indexed citations

2.

Tuohy, Orla, Lisa Costelloe, Grant Hill-Cawthorne, et al.. (2014). Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy. Journal of Neurology Neurosurgery & Psychiatry. 86(2). 208–215. 176 indexed citations

3.

Azzopardi, Laura, Richard Parker, Orla Tuohy, et al.. (2014). Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity. Neurology. 82(24). 2158–2164. 51 indexed citations

4.

Azzopardi, Laura, Sara Thompson, Katharine Harding, et al.. (2013). Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 85(7). 795–798. 40 indexed citations

5.

Williams, Thomas, Alasdair Coles, & Laura Azzopardi. (2013). The Outlook for Alemtuzumab in Multiple Sclerosis. BioDrugs. 27(3). 181–189. 5 indexed citations

6.

Jones, Joanne, Sara Thompson, Jessica L. Davies, et al.. (2013). Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation. Proceedings of the National Academy of Sciences. 110(50). 20200–20205. 158 indexed citations

7.

Azzopardi, Laura, et al.. (2012). Psychological Stress amongst Maltese Undergraduate Medical Students. International journal of collaborative research on internal medicine & public health. 4(5). 0–0. 2 indexed citations

8.

Azzopardi, Laura & Alasdair Coles. (2011). Alemtuzumab in Multiple Sclerosis. Nöro Psikiyatri Arşivi. 48(2). 79–82. 1 indexed citations

9.

Azzopardi, Laura, et al.. (2010). Myxoedema madness. BMJ Case Reports. 2010. bcr0320102841–bcr0320102841. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact